drugset / Trial / NCT06539013
Efficacy of Remifentanil in Preventing Emergence Agitation
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary aim of the study was to test the hypothesis that remifentanil administered for analgesia prevents emergence agitation more effectively than fentanyl and N2O in patients undergoing rhinoplasty who received desflurane as an inhaled anesthetic agent. The secondary aim of the study was to compare the demographic data, intraoperative and postoperative hemodynamic data, surgical time and modified Aldrete score of patients who received different intraoperative analgesia methods.
Timeline
- Start
- 2024-08-01
- Primary completion
- 2024-09-30
- Completion
- 2024-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fentanyl | Other / unclassified | 1 ug/kg | Intravenous |
| Comparator | Nitrous Oxide | Other / unclassified | — | — |
| Comparator | Remifentanil | Small molecule | 0.05 ug/kg | Intravenous |
| Comparator | Remifentanil | Small molecule | 0.2 ug/kg | Intravenous |
Indications
No indication recorded.